Popular Trials
Opioid Agonist
Buprenorphine/naloxone for Opioid Use Disorder
Recruiting3 awards6 criteria
Baltimore, Maryland
This trial tests a new device called BupreCare that helps people with opioid addiction take their medication correctly. The device locks the pills and only gives the right amount at the right time, while also tracking when the medication is taken. This helps doctors monitor their patients and improve treatment outcomes. Buprenorphine is a medication approved in the United States for the treatment of opioid dependence, offering a safe and effective alternative for individuals with opioid addiction.
Popular Filters
Phase 3 Trials
Opioid Agonist
Extended-release vs Sublingual Buprenorphine for Opioid Use Disorder
Recruiting2 awardsPhase 3
Garberville, California
This trial will explore how well an extended-release injectable medication helps people with opioid use disorder in rural areas. It will compare it to a standard medication. Results will include patient outcomes.
Opioid Partial Agonist
Buprenorphine + XR-Naltrexone for Opioid Use Disorder
Recruiting0 awardsPhase 2 & 3
New York, New York
This trial will compare the effectiveness of a new drug combination to treating opioid addiction with extended release naltrexone alone. It is a double-blind, placebo-controlled study, meaning neither the participants nor the researchers will know who is receiving the new treatment or the placebo. The study will last 24 weeks, during which participants will receive six injections of either the new treatment or a placebo. The study's goal is to see if the new treatment can improve treatment retention, reduce opioid craving, and improve mood.
Opioid Agonist
Buprenorphine/Naloxone Dosing Strategies for Opioid Use Disorder
Recruiting3 awardsPhase 2 & 3
Edmonton, Alberta
This trial will compare the effectiveness of two different regimens for taking buprenorphine/naloxone to treat opioid addiction. One group will take increasing doses of the medication until they reach an effective level, while the other group will take a standard dose.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.